NanoHive Medical, a Boston, MA-based firm which specialises in 3D-printed titanium spinal interbody fusion gadgets, raised $7M in Sequence C funding.
Backers weren’t disclosed.
The corporate intends to make use of the funds to increase the U.S. business group and its progressive Hive™ portfolio of Delicate Titanium® spinal interbody fusion gadgets by the use of product line-extensions, product launches, and “sensible” sensor implant supply analysis and growth, enter in choose worldwide markets and increase strategic partnerships.
Led by CEO Patrick O’Donnell, NanoHive Medical is an innovator in 3D printed spinal interbody fusion implants and instrumentation. The Hive™ portfolio of interbody fusion gadgets present surgeons and their sufferers supreme biomechanical elastic modulus properties, clear and exact diagnostic imaging functionality, osteoblast cell attraction and integration – all options that result in fusion constructs and efficacious scientific experiences.
The corporate additionally added Greg Hoffman and David Scott to its Managing Administrators Board.
FinSMEs
05/08/2024
